Charlotte Schubert

The Sylvester Comprehensive Cancer Center researcher discusses brain tumor vulnerabilities and the use of precision medicine to find cancer cures.

Sylvester researchers will explore a new way to treat one of the deadliest tumor types, pancreatic cancer, with funding from a new grant.

Pancreatic cancer care at Sylvester is tailored to each patient near where they live and provides access to expertise throughout treatment.

Sylvester Comprehensive Cancer Center leads a major global effort to understand risk factors for breast cancer in the Caribbean population.

The Sylvester associate director for translational research connects researchers to help bring scientific findings closer to the clinic.

Sylvester's Craig Moskowitz, M.D., helped design a study that showed improved outcomes for Hodgkin lymphoma patients.

Dr. Nimer’s commitment to mentorship and excellence infuses the culture and established Sylvester's collaborative environment.

A major research project led by Sylvester researcher Dr. C. Ola Landgren helped accelerate drug approval in multiple myeloma.

Sylvester multiple myeloma researchers are leading a field transformed by new immunotherapy drugs and targeted therapies.

Disease-causing mutations are found at higher rates in smokers with myelodysplastic syndromes compared with non-smokers.